Featured Research

from universities, journals, and other organizations

Current Drug Can Treat Rare Heart Disorder

Date:
April 12, 2009
Source:
University of Newcastle, Australia
Summary:
New research has found that the answer to treating a rare inherited heart disorder could lie with a drug already on the market.

New research has found that the answer to treating a rare inherited heart disorder could lie with a drug already on the market.

Related Articles


Associate Professor Derek Laver from the University of Newcastle and international colleagues have found that Flecainide – a drug used to treat heart arrhythmias – could also be used to treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).

CVPT is a heart arrhythmia induced by emotional stress or exercise. It is estimated to cause 15 per cent of all unexplained sudden cardiac deaths in people under the age of 30.

Associate Professor Laver said CPVT was caused by too much calcium being released from calcium stores within the heart cells.

"Correct calcium flow within the heart cells is essential for the heart to function properly," he explained. "Calcium is released from the stores into the heart cells through specific channels and we have found that Flecainide reduces the ability of these channels to release calcium, thereby directly counteracting the cause of CPVT."

Currently, beta-blockers are used to treat CPVT but 37 per cent of patients are unresponsive and 24 per cent suffer sudden cardiac death within 10 years of beginning treatment.

Implantable defibrillators are used to prevent sudden death but these cause painful electric shocks that can trigger further stress-induced arrhythmias.

"Current treatments are largely ineffective and we need new and more effective anti-arrhythmic drugs," Associate Professor Laver said.

"We have now discovered something close to an ideal drug for this rare arrhythmia disorder."

The research is published in the latest edition of the Nature Medicine journal. It was funded by several research agencies including the University of Newcastle through the Gladys M. Brawn Memorial Fellowship; and the NSW government via an infrastructure grant to the Hunter Medical Research Institute (HMRI).

Associate Professor Laver works in collaboration with HMRI's Cardiovascular Health Research Program. HMRI is a partnership between the University of Newcastle, Hunter New England Health and the community.


Story Source:

The above story is based on materials provided by University of Newcastle, Australia. Note: Materials may be edited for content and length.


Cite This Page:

University of Newcastle, Australia. "Current Drug Can Treat Rare Heart Disorder." ScienceDaily. ScienceDaily, 12 April 2009. <www.sciencedaily.com/releases/2009/04/090402092720.htm>.
University of Newcastle, Australia. (2009, April 12). Current Drug Can Treat Rare Heart Disorder. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2009/04/090402092720.htm
University of Newcastle, Australia. "Current Drug Can Treat Rare Heart Disorder." ScienceDaily. www.sciencedaily.com/releases/2009/04/090402092720.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Just A Half-Hour Of Lost Sleep Could Lead To Weight Gain

Just A Half-Hour Of Lost Sleep Could Lead To Weight Gain

Newsy (Mar. 6, 2015) A new study found losing just half an hour of sleep could make you gain weight. Video provided by Newsy
Powered by NewsLook.com
Suicide Rates Up For Young Women In U.S.

Suicide Rates Up For Young Women In U.S.

Newsy (Mar. 6, 2015) According to a report from the CDC, suicide rates among young women increased from 1994 to 2012 while rates among young men have decreased. Video provided by Newsy
Powered by NewsLook.com
Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Liberia Releases Last Ebola Patient, But Threat Remains

Liberia Releases Last Ebola Patient, But Threat Remains

Newsy (Mar. 5, 2015) Liberia&apos;s last Ebola patient has been released, and the country hasn&apos;t recorded a new case in a week. However, fears of another outbreak still exist. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins